Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.

Pharmacogenomics - 1 Jul 2008

Gupta Meenal, Kaur Harpreet, Grover Sandeep, Kukreti Ritushree

Abstract excerpt

Pharmacogenomics is the study of interindividual genetic variability, which plays a significant role in defining drug response and toxicity. As research has graduated from studying single candidate genes to whole-genome scans, pharmacogenomics is beginning to make its impact on the therapeutics of complex CNS disorders, such as schizophrenia, Parkinson's disease and Alzheimer's disease. Alzheimer's disease is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Dementia
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 18597653
DOI: 10.2217/14622416.9.7.895

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.PMID 18597653Read ↗

Pharmacogenomics for the treatment of dementia.Semantic proximity Read ↗

Pharmacogenomics and therapeutic strategies for dementiaSemantic proximity Read ↗

Pharmacogenomics of neurodegenerative diseases.Semantic proximity Read ↗

Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.Semantic proximity Read ↗

Genetic variation and pharmacogenomics in Alzheimer disease.Semantic proximity Read ↗

Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive ReviewSemantic proximity Read ↗

Pharmacogenomics of Alzheimer’s and Parkinson’s diseasesSemantic proximity Read ↗

Pharmacogenetic Considerations in the Treatment of Alzheimer’s DiseaseSemantic proximity Read ↗

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.Semantic proximity Read ↗

Opportunities in pharmacogenomics for the treatment of Alzheimer’s diseaseSemantic proximity Read ↗

Pharmacogenomics and therapeutic prospects in dementiaSemantic proximity Read ↗

Pharmacogenomics in Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.